ArticlePLOS global public health2024
Evaluation of inflammation adjustment methods to assess iron deficiency using longitudinal data from norovirus human challenge trials.
Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Intermittent oral administration of iron oxide nanoparticles modulates iron homeostasis, hematological, inflammatory, and organ-specific responses in iron-deficient rats.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- The Prevalence of Nutritional Imbalances in the US Population Over Time: Biomarker Data from the Cross-Sectional National Health and Nutrition Examination Survey (NHANES 1999-2000 through August 2021-August 2023).Current developments in nutrition · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accounting for inflammation is necessary to assess iron deficiency using ferritin. A limitation of existing inflammation-adjustment methods is reliance on cross-sectional data to evaluate method performance. The study objective was to evaluate three inflammation-adjustment methods using longitudinal data from two controlled trials where apparently healthy adults (n = 52) were exposed to norovirus. Correction factors (CF), the Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) regression correction (BRC), and restricted cubic splines (RCS) were used to adjust the influence of inflammation on ferritin using alpha-1-acid glycoprotein (AGP) and/or C-reactive protein (CRP). Blood was collected at baseline (day 0, pre-exposure to norovirus) and at 9 time points post-exposure (days 1, 2, 3, 4, 7, 14, 21, 28, and 35). Inflammation-adjusted ferritin concentrations were compared with 1) baseline, 2) endline, 3) the average of baseline and endline, and 4) predicted ferritin concentrations among subjects with infection, expressed as percent difference. The predicted ferritin concentrations were modeled using data from 26 subjects without infection in a linear mixed model. Adjusting for CRP or AGP, the median differences between adjusted ferritin using CF, BRC, and RCS were respectively [0.2%, 2.5%], [-22.2%, -20.8%], [-16.7%, -7.1%] compared with the average of baseline and endline values and were 0%, [-16.8%, -18.5%], [-8.9%, -2.8%] compared with predicted ferritin concentrations. For BRC, adjusting for both CRP and AGP tended to result in more over-adjustment of ferritin compared to using a single inflammatory protein. The BRC appeared to overcorrect ferritin in this study setting, while the CF yielded adjusted ferritin concentrations closer to the average baseline and endline concentrations and the predicted concentrations. Longitudinal studies with larger sample sizes exposed to other infectious agents are needed to further evaluate inflammation-adjustment methods and the need for including multiple inflammation biomarkers.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.